Assessing the treatment effect in a randomized controlled trial with extensive non‐adherence: the EVOLVE trial

By  

PHARMACEUTICAL STATISTICS: THE JOURNAL OF APPLIED STATISTICS IN THE PHARMACEUTICAL INDUSTRY, Vol. 14, Iss. 3, 2015-05 ,pp. : 242-251

John Wiley & Sons Inc

Access to resources Recommend Favorite

Assessing potentially time‐dependent treatment effect from clinical trials and observational studies for survival data, with applications to the Women's Health Initiative combined hormone therapy trial

By  

STATISTICS IN MEDICINE, Vol. 34, Iss. 11, 2015-05 ,pp. : 1801-1817

John Wiley & Sons Inc

Access to resources Recommend Favorite

Influence of trial duration on the bias of the estimated treatment effect in clinical trials when individual heterogeneity is ignored

By  

BIOMETRICAL JOURNAL, Vol. 57, Iss. 3, 2015-05 ,pp. : 371-383

John Wiley & Sons Inc

Access to resources Recommend Favorite

Flexible selection of a single treatment incorporating short‐term endpoint information in a phase II/III clinical trial

By  

STATISTICS IN MEDICINE, Vol. 34, Iss. 23, 2015-10 ,pp. : 3104-3115

John Wiley & Sons Inc

Access to resources Recommend Favorite

Sample size determination for testing nonequality under a three‐treatment two‐period incomplete block crossover trial

By  

BIOMETRICAL JOURNAL, Vol. 57, Iss. 3, 2015-05 ,pp. : 410-421

John Wiley & Sons Inc

Access to resources Recommend Favorite